Boston Scientific Corporation stock page - price, fundamentals, dividends - iOCharts

Ticker
BSX

Price
39.66
Stock movement up
+0.87 (2.24%)
Company name
Boston Scientific Corporation
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Medical Devices
Market cap
56.69B
Ent value
71.97B
Price/Sales
4.66
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
3.70%
Trailing P/E
69.99
Forward P/E
19.63
PEG
9.78
EPS growth
108.20%
1 year return
-4.55%
3 year return
2.28%
5 year return
8.62%
10 year return
20.45%
Last updated: 2022-05-13

DIVIDENDS

BSX does not pay dividends

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E69.99
Price to OCF35.75
Price to FCF51.21
Price to EBITDA30.86
EV to EBITDA39.18

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales4.66
Price to Book-
EV to Sales5.92

FINANCIALS

Per share

Loading...
Per share data
Current share count1.43B
EPS (TTM)-
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)12.16B
Gross profit (TTM)8.34B
Operating income (TTM)1.31B
Net income (TTM)810.00M
EPS (TTM)-
EPS (1y forward)2.02

Margins

Loading...
Margins data
Gross margin (TTM)68.58%
Operating margin (TTM)10.78%
Profit margin (TTM)6.66%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash325.00M
Net receivables1.87B
Total current assets5.07B
Goodwill12.95B
Intangible assets6.58B
Property, plant and equipment0.00
Total assets32.34B
Accounts payable3.00B
Short/Current long term debt0.00
Total current liabilities4.28B
Total liabilities15.60B
Shareholder's equity0.00
Net tangible assets-1.60B

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)1.59B
Capital expenditures (TTM)479.00M
Free cash flow (TTM)1.11B
Dividends paid (TTM)41.00M

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open39.16
Daily high39.92
Daily low39.13
Daily Volume7.14M
All-time high47.10
1y analyst estimate51.04
Beta0.83
EPS (TTM)-
Dividend per share-
Ex-div date-
Next earnings date25 Jul 2022

Downside potential

Loading...
Downside potential data
BSXS&P500
Current price drop from All-time high-15.80%-15.91%
Highest price drop-89.15%-56.47%
Date of highest drop26 Jul 20129 Mar 2009
Avg drop from high-42.90%-11.33%
Avg time to new high46 days12 days
Max time to new high4361 days1805 days
COMPANY DETAILS
BSX (Boston Scientific Corporation) company logo
Marketcap
56.69B
Marketcap category
Large-cap
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Employees
41000
SEC filings
CEO
Michael Mahoney
Country
USA
City
Marlborough
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Boston Scientific Corporation ( NYSE:BSX ) shareholders might be concerned after seeing the share price drop 11% in the...
May 13, 2022
A key lesson of the pandemic is that we must keep mental health squarely on the workplace agenda. When employees take better care of their health, they're happier and more productive. The airlines ...
May 6, 2022
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
May 5, 2022
Boston Scientific Corporation (NYSE: BSX) will participate in Bank of America's Global Healthcare Conference on Thursday, May 12.
May 2, 2022
Statements and Voting Guidance from Major Investors May Offer Companies a Roadmap For What Lies Ahead
April 29, 2022
Boston Scientific eked out a narrow first-quarter beat that also topped industry trends, an analyst said Wednesday as BSX stock popped.
April 27, 2022
With me on today's call are Mike Mahoney, chairman and chief executive officer; and Dan Brennan, executive vice president and chief financial officer. The duration of this morning's call will be appr...
April 27, 2022
Boston Scientific (BSX) registers a year-over-year improvement in organic sales, indicating a strong rebound in the legacy business from the pandemic mayhem.
April 27, 2022
View more earnings on BSXSee more from BenzingaAcutus Medical Stock Soars On Debt Refinancing, Divestiture Of Left-Heart Access PortfolioDaiichi Sankyo - AstraZeneca's Enhertu Receives Third Breakthro...
April 27, 2022
Stock in the medical-device company has held its ground this year even as the tech-heavy Nasdaq Composite has plunged.
April 27, 2022
Next page